ERLI PLUS 12.5MG 500MG TAB (14s)
ERLI PLUS 12.5mg/500mg Tablets (14s) combine empagliflozin and metformin, offering an effective treatment for type 2 diabetes mellitus. This dual-action formula helps control blood sugar levels by improving insulin sensitivity, reducing glucose production in the liver, and promoting glucose excretion through urine. It supports better glycemic control, reduces the risk of diabetic complications, and aids in weight management when combined with diet and exercise.
Uses:
-
Helps control blood sugar levels in type 2 diabetes.
-
Used as part of a comprehensive diabetes management plan.
-
Reduces the risk of cardiovascular complications in diabetic patients.
Benefits:
-
Dual mechanism for enhanced blood glucose control.
-
Supports weight reduction and improved metabolism.
-
May lower the risk of heart disease in diabetic individuals.
-
Convenient once-daily dosing for patient compliance.
Side Effects:
-
Common: Increased urination, thirst, nausea, or diarrhea.
-
Rare: Dehydration, low blood sugar (hypoglycemia) when used with other antidiabetics, or urinary tract infections.
-
Consult a doctor before use, especially in patients with kidney or liver disease.